Literature DB >> 12048357

gp120-Independent infection of CD4(-) epithelial cells and CD4(+) T-cells by HIV-1.

Yen-Hung Chow1, Duan Yu, Jun-Ying Zhang, Yiming Xie, O Lu-Chen Wei, Christopher Chiu, Mani Foroohar, Otto O Yang, No-Hee Park, Irvin S Y Chen, Shen Pang.   

Abstract

Infection of CD4- cells by HIV-1 is well documented, but the mechanism responsible remains a matter of discussion. Previously we modified an HIV-1 virus strain, NL4-3, by deleting the Env proteins (gp41 and gp120) and inserting the enhanced green fluorescent protein (EGFP), and found that the Env(-) virus infects several types of CD4- cells. Here, we have prepared Env(-) virus from both the CD4- cell line, 293T, and the CD4+ cell lines, CEM and SUPT1, and found that HIV-1 Env(-) virus from either cell type is infectious for both CD4+ and several CD4- cell lines. Replication of HIV-1 Env(-) virus-infected cells was demonstrated by p24 gag protein assays and real-time reverse transcriptase polymerase chain reaction (RT-PCR) of the culture medium from infected cells. Virus collected from the HIV-1-Env(-) infected cultures proved infectious to several CD4- cell lines. Our results suggest that HIV-1 infects both CD4- and CD4+ cells using a gp120-independent mechanism. This infection mechanism may provide new explanations for HIV-1 latency and persistent infection in patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12048357     DOI: 10.1097/00042560-200205010-00001

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

2.  Involvement of non-structural proteins (NS) in influenza A infection and viral tropism.

Authors:  Xinmin Yan; Qiuwei Wang; Zhiqing Zhang; Yiming Xie; Hong Zhang; Miriam Razi; Shen Hu; Lijun Zhang; Jinluo Cheng; Shen Pang
Journal:  Biochem Biophys Res Commun       Date:  2012-10-08       Impact factor: 3.575

3.  Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.

Authors:  Renaud Burrer; Sandrine Haessig-Einius; Anne-Marie Aubertin; Christiane Moog
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Proteomic signatures of human oral epithelial cells in HIV-infected subjects.

Authors:  Elizabeth Yohannes; Santosh K Ghosh; Bin Jiang; Thomas S McCormick; Aaron Weinberg; Edward Hill; Faddy Faddoul; Mark R Chance
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

5.  Involvement of claudin-7 in HIV infection of CD4(-) cells.

Authors:  Junying Zheng; Yiming Xie; Richard Campbell; Jun Song; Samira Massachi; Miriam Razi; Robert Chiu; James Berenson; Otto O Yang; Irvin S Y Chen; Shen Pang
Journal:  Retrovirology       Date:  2005-12-20       Impact factor: 4.602

Review 6.  Exosomes in Human Immunodeficiency Virus Type I Pathogenesis: Threat or Opportunity?

Authors:  Sin-Yeang Teow; Alif Che Nordin; Syed A Ali; Alan Soo-Beng Khoo
Journal:  Adv Virol       Date:  2016-01-04

7.  Role of TIM-4 in exosome-dependent entry of HIV-1 into human immune cells.

Authors:  Brian Sims; Anitra L Farrow; Sparkle D Williams; Anju Bansal; Alexandre Krendelchtchikov; Linlin Gu; Qiana L Matthews
Journal:  Int J Nanomedicine       Date:  2017-07-06

Review 8.  Dendritic Cells, the Double Agent in the War Against HIV-1.

Authors:  Alba Martín-Moreno; Mª Angeles Muñoz-Fernández
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

9.  HIV-1 infection of DC: evidence for the acquisition of virus particles from infected T cells by antigen uptake mechanism.

Authors:  Narasimhan J Venkatachari; Sean Alber; Simon C Watkins; Velpandi Ayyavoo
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.